Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sellas Life Sciences Group Inc SLS

SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the development of therapeutics for a range of cancer indications. The Company's product candidates are galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1 (WT1), antigen, and SLS009, a selective small molecule cyclin-dependent kinase 9 (CDK9) inhibitor... see more

Bullboard (NDAQ:SLS)

View:
User Avatar Image
(10)
•••
  • MikeTesterX
Post by MikeTesteron Jan 24, 2025 11:05am

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS): A Pioneering

Looks like SELLAS is cooking up something big in the cancer treatment space. 50% response rate in AML with SLS009 is no joke. Especially that 100% response in ASXL1 mutated patients - that's a ...more  
User Avatar Image
(107)
•••
  • IseneschalX
Post by Iseneschalon Nov 13, 2023 8:53am

SLS....NR bump

FDA mentioned....$1.04
Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities